SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-04-000826
Filing Date
2004-08-13
Accepted
2004-08-13 17:30:06
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTER ENDED JUNE 30, 2004 a01127e10vq.htm 10-Q 294379
2 EXHIBIT 15 a01127exv15.txt EX-15 1358
3 EXHIBIT 31.1 a01127exv31w1.txt EX-31.1 3113
4 EXHIBIT 31.2 a01127exv31w2.txt EX-31.2 3103
5 EXHIBIT 32.1 a01127exv32w1.txt EX-32.1 1549
6 EXHIBIT 32.2 a01127exv32w2.txt EX-32.2 1545
7 GRAPHIC a01127a0112700.gif GRAPHIC 14736
  Complete submission text file 0000936392-04-000826.txt   322129
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 04975528
SIC: 2834 Pharmaceutical Preparations